The fastest-growing and largest of the 20 sized Pharmaceuticals markets in Europe, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $7 Bn | $58.5 Bn | 23.6% | 41 |
| 2 | Cell Based Immunotherapy | $3.2 Bn | $22.6 Bn | 21.7% | 4,342 |
| 3 | Cannabidiol (CBD) | $4.2 Bn | $17.8 Bn | 15.5% | 37 |
| 4 | Cannabis | $6.4 Bn | $20.4 Bn | 12.2% | 88 |
| 5 | Atopic Dermatitis Drugs | $2.1 Bn | $6 Bn | 10.9% | 88 |
| 6 | Oncology/Cancer Drugs | $33.6 Bn | $67 Bn | 7.1% | 4,287 |
| 7 | Anti-Aging | $16.8 Bn | $32.5 Bn | 6.8% | 400 |
| 8 | Diabetes Management | $14.8 Bn | $26.1 Bn | 5.8% | 530 |
| 9 | Alzheimer Drugs | $952 Mn | $1.6 Bn | 5.5% | 242 |
| 10 | Contraceptives Drugs | $4.8 Bn | $8.2 Bn | 5.5% | 10 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $33.6 Bn | $67 Bn | 7.1% | 4,287 |
| 2 | Anti-Aging | $16.8 Bn | $32.5 Bn | 6.8% | 400 |
| 3 | Diabetes Management | $14.8 Bn | $26.1 Bn | 5.8% | 530 |
| 4 | Gastrointestinal Drugs | $10.3 Bn | $14.3 Bn | 3.3% | 1,923 |
| 5 | Asthma & COPD Drugs | $9.4 Bn | $12.3 Bn | 2.7% | 304 |
| 6 | Biosimilars | $7 Bn | $58.5 Bn | 23.6% | 41 |
| 7 | Cannabis | $6.4 Bn | $20.4 Bn | 12.2% | 88 |
| 8 | HIV Drugs | $5.7 Bn | $8.9 Bn | 4.5% | 104 |
| 9 | Contraceptives Drugs | $4.8 Bn | $8.2 Bn | 5.5% | 10 |
| 10 | Cancer Supportive Care Drugs | $4.7 Bn | $6.6 Bn | 3.4% | 758 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in UK, Germany, France, Italy, Spain, Russia.
Biosimilars grows fastest, at 23.6% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (21.7%).
Oncology/Cancer Drugs is the largest, worth about $33.6 Bn in 2023 and $67 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.